Related Experiment Video
Updated: Mar 30, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
The Immune Phenotype of Patients with CHARGE Syndrome
Peter Hsu1, Alan Ma2, Elizabeth H Barnes3
1Department of Allergy and Immunology, The Children's Hospital at Westmead, Sydney, Australia.
Insights
Children with CHARGE syndrome show few immune defects, unlike those with 22q11.2 deletion. Both conditions can cause early lymphopenia and hypocalcemia, but it is more severe in 22q11.2 deletion.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Recurrent sinopulmonary infections are common in children with CHARGE syndrome.
- Prospective studies on immune function in CHARGE syndrome are lacking.
Purpose of the Study:
- To compare the immune phenotype of CHARGE syndrome patients with 22q11.2 deletion patients and healthy controls.
- To investigate immune function in CHARGE syndrome.
Main Methods:
- Assessed lymphocyte subsets, immunoglobulins, and vaccine responses in 21 CHARGE syndrome patients.
- Compared immune parameters and calcium levels in CHARGE syndrome and 40 22q11.2 deletion patients.
- Included 55 healthy controls for comparison.
Main Results:
- Only 2 CHARGE syndrome patients had identifiable immune defects (reduced IgA).
- 22q11.2 deletion patients exhibited T-cell lymphopenia, low immunoglobulins, and antibody deficiency.
- Lymphopenia and hypocalcemia were more pronounced in 22q11.2 deletion patients within the first 72 months.
Conclusions:
- CHARGE syndrome patients in this cohort showed no significant immune defects at testing.
- Phenotypic overlap exists between CHARGE and 22q11.2 deletion syndromes.
- Early-life lymphopenia and hypocalcemia are present in both, but more severe in 22q11.2 deletion syndrome.
Background:
Recurrent sinopulmonary infections are common in children with CHARGE (Coloboma, Heart disease, choanal Atresia, growth/mental Retardation, Genitourinary malformations, Ear abnormalities) syndrome, but no prospective studies on immune function have been conducted.
Objective:
This study aims to examine and compare the immune phenotype of patients with CHARGE syndrome to those with 22q11.2 deletion and healthy controls.
Methods:
A total of 21 patients attended a multidisciplinary CHARGE clinic. All patients had CHD7 mutational analysis performed. Patients with CHARGE syndrome had lymphocyte subsets, immunoglobulins (IgG, A, M), functional protein, and polysaccharide vaccine responses measured at initial evaluation. A total of 55 healthy controls were prospectively recruited, whereas 40 patients with 22q11.2 deletion were retrospectively identified through medical records. A separate analysis compared serial lymphocyte counts and ionized calcium levels between patients with CHARGE syndrome and those with 22q11.2 deletion in the first 72 months of life.
Results:
Despite recurrent childhood ear and chest infections, only 2 children with CHARGE syndrome had an identifiable immune defect (reduced serum IgA). In contrast, T-cell lymphopenia, low immunoglobulin levels, and specific antibody deficiency were noted in patients with 22q11.2 deletion. A greater proportion of patients with 22q11.2 deletion had persistent lymphopenia (57% vs 30%) and hypocalcemia (60% vs 37.5%) compared with patients with CHARGE syndrome in the first 72 months of life.
Conclusions:
Although phenotypic overlap exists between CHARGE and 22q11.2 deletion syndromes, no significant immune defects were detected in this cohort of patients with CHARGE syndrome at the time of testing. Lymphopenia and hypocalcemia occur in both conditions early in life, but is more pronounced in patients with 22q11.2 deletion.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12:36Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pleiotropy
Multiple Allele Traits
Pedigree Analysis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...